Unique Spectrum of Activating BRAF Alterations in Prostate Cancer

PURPOSE: Alterations in BRAF have been reported in 3% to 5% of prostate cancer, although further characterization is lacking. Here, we describe the nature of BRAF alterations in prostate cancer using a large cohort from commercially available tissue and liquid biopsies subjected to comprehensive gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chehrazi-Raffle, Alex, Tukachinsky, Hanna, Toye, Eamon, Sivakumar, Smruthy, Schrock, Alexa B., Bergom, Hannah E., Ebrahimi, Hedyeh, Pal, Sumanta, Dorff, Tanya, Agarwal, Neeraj, Mahal, Brandon A., Oxnard, Geoffrey R., Hwang, Justin, Antonarakis, Emmanuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543965/
https://www.ncbi.nlm.nih.gov/pubmed/37477913
http://dx.doi.org/10.1158/1078-0432.CCR-23-1393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543965/
https://www.ncbi.nlm.nih.gov/pubmed/37477913
http://dx.doi.org/10.1158/1078-0432.CCR-23-1393

Ejemplares similares